{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:43:04Z","timestamp":1791243784749,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["atherosclerosis-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.atherosclerosis.2015.02.027","type":"journal-article","created":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T03:21:04Z","timestamp":1424748064000},"page":"53-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["A phase 2 randomized, double-blind, placebo-controlled study of the effect of VIA-2291, a 5-lipoxygenase inhibitor, on vascular inflammation in patients after an acute coronary syndrome"],"prefix":"10.1016","volume":"240","author":[{"given":"Juan","family":"Gaztanaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Farkouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.F.","family":"Rudd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilmann M.","family":"Brotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rosenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0432-2918","authenticated-orcid":false,"given":"Venkatesh","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd C.","family":"Kerwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Taub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Tardif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Tawakol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahi A.","family":"Fayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.atherosclerosis.2015.02.027_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2013an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"32","key":"10.1016\/j.atherosclerosis.2015.02.027_bib2","doi-asserted-by":"crossref","first-page":"11779","DOI":"10.1073\/pnas.0403259101","article-title":"Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques","volume":"101","author":"Llodra","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"21","key":"10.1016\/j.atherosclerosis.2015.02.027_bib3","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1161\/01.CIR.0000128520.37674.EF","article-title":"Atherosclerotic vascular disease conference: writing group III: pathophysiology","volume":"109","author":"Faxon","year":"2004","journal-title":"Circulation"},{"issue":"Suppl.\u00a06A","key":"10.1016\/j.atherosclerosis.2015.02.027_bib4","doi-asserted-by":"crossref","first-page":"9S","DOI":"10.1016\/j.amjmed.2004.02.006","article-title":"Inflammation and atherosclerosis: role of C-reactive protein in risk assessment","volume":"116","author":"Libby","year":"2004","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.02.027_bib5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ajem.2010.11.006","article-title":"Serum highly selective C-reactive protein concentration is associated with the volume of ischemic tissue in acute ischemic stroke","volume":"30","author":"Youn","year":"2012","journal-title":"Am. J. Emerg. Med."},{"issue":"13","key":"10.1016\/j.atherosclerosis.2015.02.027_bib6","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1056\/NEJM200009283431303","article-title":"Multiple complex coronary plaques in patients with acute myocardial infarction","volume":"343","author":"Goldstein","year":"2000","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.02.027_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJMoa012295","article-title":"Widespread coronary inflammation in unstable angina","volume":"347","author":"Buffon","year":"2002","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2015.02.027_bib8","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0735-1097(02)02376-8","article-title":"Multicentric inflammation in epicardial coronary arteries of patients dying of acute myocardial infarction","volume":"40","author":"Spagnoli","year":"2002","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2015.02.027_bib9","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1161\/01.CIR.0000025609.13806.31","article-title":"Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study","volume":"106","author":"Rioufol","year":"2002","journal-title":"Circulation"},{"issue":"7407","key":"10.1016\/j.atherosclerosis.2015.02.027_bib10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nature11260","article-title":"Myocardial infarction accelerates atherosclerosis","volume":"487","author":"Dutta","year":"2012","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.atherosclerosis.2015.02.027_bib11","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/01.CIR.97.20.2007","article-title":"C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction","volume":"97","author":"Ridker","year":"1998","journal-title":"Circulation"},{"issue":"9050","key":"10.1016\/j.atherosclerosis.2015.02.027_bib12","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0140-6736(96)07591-5","article-title":"Production of C-reactive protein and risk of coronary events in stable and unstable angina. European concerted action on thrombosis and disabilities angina pectoris study group","volume":"349","author":"Haverkate","year":"1997","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2015.02.027_bib13","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199408183310701","article-title":"The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina","volume":"331","author":"Liuzzo","year":"1994","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2015.02.027_bib14","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0735-1097(00)00581-7","article-title":"Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet therapy in unstable angina refractory to standard treatment trial","volume":"35","author":"Heeschen","year":"2000","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2015.02.027_bib15","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/01.CIR.103.7.926","article-title":"Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization","volume":"103","author":"Crisby","year":"2001","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.02.027_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0021-9150(03)00158-8","article-title":"Relationship between effects of statins, aspirin and angiotensin II modulators on high-sensitive C-reactive protein levels","volume":"169","author":"Takeda","year":"2003","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2015.02.027_bib17","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jcmg.2011.08.007","article-title":"Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET\/CT imaging study of carotid artery and ascending aorta","volume":"4","author":"Mizoguchi","year":"2011","journal-title":"JACC Cardiovasc. imaging"},{"issue":"13","key":"10.1016\/j.atherosclerosis.2015.02.027_bib18","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"issue":"4597","key":"10.1016\/j.atherosclerosis.2015.02.027_bib19","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1126\/science.6301011","article-title":"Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation","volume":"220","author":"Samuelsson","year":"1983","journal-title":"Science"},{"issue":"4819","key":"10.1016\/j.atherosclerosis.2015.02.027_bib20","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1126\/science.2820055","article-title":"Leukotrienes and lipoxins: structures, biosynthesis, and biological effects","volume":"237","author":"Samuelsson","year":"1987","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2015.02.027_bib21","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0009-9236(98)90164-3","article-title":"Pharmacokinetics and pharmacodynamics of single and multiple oral doses of a novel 5-lipoxygenase inhibitor (ABT-761) in healthy volunteers","volume":"63","author":"Wong","year":"1998","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.atherosclerosis.2015.02.027_bib22","article-title":"Abstract: attenuation of atherosclerosis and monocyte-macrophage inflammation in ApoE-deficient mice treated with the 5-lipoxygenase inhibitor VIA-2291","volume":"116","author":"Hansson","year":"2007","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2015.02.027_bib23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/CIRCIMAGING.110.937169","article-title":"Treatment with 5-lipoxygenase inhibitor VIA-2291 (Atreleuton) in patients with recent acute coronary syndrome","volume":"3","author":"Tardif","year":"2010","journal-title":"Circ. Cardiovasc. Imaging"},{"issue":"23","key":"10.1016\/j.atherosclerosis.2015.02.027_bib24","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1161\/01.CIR.0000020548.60110.76","article-title":"Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography","volume":"105","author":"Rudd","year":"2002","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2015.02.027_bib25","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.jacc.2006.05.076","article-title":"In\u00a0vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients","volume":"48","author":"Tawakol","year":"2006","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"9802","key":"10.1016\/j.atherosclerosis.2015.02.027_bib26","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S0140-6736(11)61383-4","article-title":"Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial","volume":"378","author":"Fayad","year":"2011","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2015.02.027_bib27","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jacc.2007.05.024","article-title":"(18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials","volume":"50","author":"Rudd","year":"2007","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2015.02.027_bib28","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jacc.2013.04.066","article-title":"Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography\/computed tomography feasibility study","volume":"62","author":"Tawakol","year":"2013","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.02.027_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa025079","article-title":"Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis","volume":"350","author":"Dwyer","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2015.02.027_bib30","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/9680","article-title":"Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment","volume":"22","author":"Drazen","year":"1999","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2015.02.027_bib31","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/hrt.2006.112508","article-title":"Intensive statin therapy in acute coronary syndromes and stable coronary heart disease: a comparative meta-analysis of randomised controlled trials","volume":"93","author":"Afilalo","year":"2007","journal-title":"Heart"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2015.02.027_bib32","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2007.02.013","volume":"50","author":"Anderson","year":"2007","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"15","key":"10.1016\/j.atherosclerosis.2015.02.027_bib33","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2015.02.027_bib34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00259-011-1994-7","article-title":"The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkers","volume":"39","author":"Wu","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2015.02.027_bib35","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.jacc.2006.03.069","article-title":"Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography","volume":"48","author":"Tahara","year":"2006","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.02.027_bib36","doi-asserted-by":"crossref","DOI":"10.1161\/circ.124.suppl_21.A18242","article-title":"High dose statin results in a further reduction in atherosclerotic inflammation comapred with low dose statin: results of a Multi-Center PET-CT study","volume":"124","author":"Tawakol","year":"2011","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.atherosclerosis.2015.02.027_bib37","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"13","key":"10.1016\/j.atherosclerosis.2015.02.027_bib38","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1161\/01.CIR.0000091404.09558.AF","article-title":"High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study","volume":"108","author":"Kinlay","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.02.027_bib39","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.amjcard.2008.02.090","article-title":"Effect of intensive atorvastatin therapy on prostaglandin E2 levels and metalloproteinase-9 activity in the plasma of patients with non-ST-elevation acute coronary syndrome","volume":"102","author":"Gomez-Hernandez","year":"2008","journal-title":"Am. J. Cardiol."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2015.02.027_bib40","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1179\/174313209X403913","article-title":"5-lipoxygenase inhibitor zileuton attenuates ischemic brain damage: involvement of matrix metalloproteinase 9","volume":"31","author":"Tu","year":"2009","journal-title":"Neurol. Res."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2015.02.027_bib41","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1476-5381.2010.00930.x","article-title":"The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages","volume":"161","author":"Rossi","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2015.02.027_bib42","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1158\/1535-7163.MCT-06-0318","article-title":"Inhibition of 5-lipoxygenase by MK886 augments the antitumor activity of celecoxib in human colon cancer cells","volume":"5","author":"Cianchi","year":"2006","journal-title":"Mol. Cancer Ther."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2015.02.027_bib43","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.02.027_bib44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"C-reactive protein levels and outcomes after statin therapy","volume":"352","author":"Ridker","year":"2005","journal-title":"N.\u00a0Engl. J. Med."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015001173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015001173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T10:58:15Z","timestamp":1717757895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915015001173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0021915015001173"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.02.027","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A phase 2 randomized, double-blind, placebo-controlled study of the effect of VIA-2291, a 5-lipoxygenase inhibitor, on vascular inflammation in patients after an acute coronary syndrome","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.02.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}